Related Experiment Video
Updated: May 25, 2026
08:01
A Streamlined, Label-Free Real-Time 50% Tissue Culture Infectious Dose (TCID50) Assay using Impedance for Automated Viral Titer Quantification
Published on: January 9, 2026
Guidelines for accurate EC50/IC50 estimation
1Sebaugh's Information Services, Columbia, MO 65203, USA. sis.stat@centurytel.net
Pharmaceutical Statistics
|February 14, 2012
Summary
This study outlines minimum requirements for reliable EC50/IC50 estimates, distinguishing between relative and absolute measures based on assay control stability and accuracy. Adhering to these guidelines ensures accurate reporting of drug efficacy and potency values.
Area of Science:
- Pharmacology
- Biostatistics
- Assay Development
Background:
- Accurate estimation of EC50/IC50 values is critical for drug discovery and development.
- Existing methods for EC50/IC50 determination lack standardized criteria for ensuring estimate reliability.
- Two definitions of EC50/IC50 (relative and absolute) exist, requiring clear guidelines for their appropriate application.
Purpose of the Study:
- To establish minimum requirements for confidence in the accuracy of EC50/IC50 estimates.
- To provide guidance on selecting between relative and absolute EC50/IC50 definitions based on assay characteristics.
- To define criteria for reportable EC50/IC50 values to enhance data consistency.
Main Methods:
- The study defines relative EC50/IC50 as the parameter 'c' in a 4-parameter logistic model and absolute EC50/IC50 as the response at 50% control.
- Guidelines are developed based on the stability and accuracy of assay controls (0%, 100%, and 50% controls).
- Criteria for the number of assay concentrations relative to model bend points and predicted responses are established for reportability.
Main Results:
- Relative EC50/IC50 is recommended for assays lacking a stable 100% control or with >5% error in the 50% control mean.
- Absolute EC50/IC50 is suitable for assays with accurate, stable 100% controls and <5% error in the 50% control mean, offering potential efficiency gains.
- Reportable relative EC50/IC50 requires at least two concentrations beyond lower/upper bend points; reportable absolute EC50/IC50 needs two concentrations below and two above 50% predicted response.
Conclusions:
- Clear guidelines are provided to ensure the accuracy and reliability of EC50/IC50 estimates in pharmacological assays.
- The choice between relative and absolute EC50/IC50 should be dictated by specific assay performance metrics, particularly control stability.
- Implementing these criteria will improve the consistency and interpretability of drug potency data in research and development.
Related Concept Videos
01:18Pharmacodynamic Models: Emax Drug–Concentration Effect Model
The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.